BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17551101)

  • 1. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.
    Ehrchen J; Helming L; Varga G; Pasche B; Loser K; Gunzer M; Sunderkötter C; Sorg C; Roth J; Lengeling A
    FASEB J; 2007 Oct; 21(12):3208-18. PubMed ID: 17551101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
    Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
    J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice.
    Mathieu C; Van Etten E; Gysemans C; Decallonne B; Kato S; Laureys J; Depovere J; Valckx D; Verstuyf A; Bouillon R
    J Bone Miner Res; 2001 Nov; 16(11):2057-65. PubMed ID: 11697802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of Leishmania major infection in mice lacking TNF receptors.
    Nashleanas M; Kanaly S; Scott P
    J Immunol; 1998 Jun; 160(11):5506-13. PubMed ID: 9605154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism.
    Korf H; Wenes M; Stijlemans B; Takiishi T; Robert S; Miani M; Eizirik DL; Gysemans C; Mathieu C
    Immunobiology; 2012 Dec; 217(12):1292-300. PubMed ID: 22944250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages.
    Stefani MM; Müller I; Louis JA
    Eur J Immunol; 1994 Mar; 24(3):746-52. PubMed ID: 7510243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of Leishmania major in the absence of Tyk2 kinase.
    Schleicher U; Mattner J; Blos M; Schindler H; Röllinghoff M; Karaghiosoff M; Müller M; Werner-Felmayer G; Bogdan C
    Eur J Immunol; 2004 Feb; 34(2):519-29. PubMed ID: 14768057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
    Aguilar-Torrentera F; Carlier Y
    Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
    Spanier JA; Nashold FE; Olson JK; Hayes CE
    J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mannose receptor during experimental leishmaniasis.
    Akilov OE; Kasuboski RE; Carter CR; McDowell MA
    J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis.
    Fritzsche C; Schleicher U; Bogdan C
    Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.
    Hall LR; Titus RG
    J Immunol; 1995 Oct; 155(7):3501-6. PubMed ID: 7561045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
    J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.